These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 8908549

  • 1. Promoter-independent loss of mRNA and protein of the Rb gene in a human hepatocellular carcinoma.
    Hada H, Koide N, Morita T, Shiraha H, Shinji T, Nakamura M, Ujike K, Takayama N, Oka T, Hanafusa T, Yumoto Y, Hamazaki K, Tsuji T.
    Hepatogastroenterology; 1996; 43(11):1185-9. PubMed ID: 8908549
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.
    Mori T, Nomoto S, Koshikawa K, Fujii T, Sakai M, Nishikawa Y, Inoue S, Takeda S, Kaneko T, Nakao A.
    Liver Int; 2005 Apr; 25(2):380-8. PubMed ID: 15780064
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan.
    Hsu LS, Lee HC, Chau GY, Yin PH, Chi CW, Lui WY.
    Oncol Rep; 2006 Feb; 15(2):507-11. PubMed ID: 16391877
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J, Wittekind C.
    Oncogene; 2001 Oct 25; 20(48):7104-9. PubMed ID: 11704835
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Methylation-related silencing of p14ARF gene correlates with telomerase activity and mRNA expression of human telomerase reverse transcriptase in hepatocellular carcinoma.
    Zhang C, Guo X, Zhang L, Lu Z, Ma N, Cheng Y, Shen F, Zhang B, Wu M, Wei L.
    J Surg Oncol; 2008 Nov 01; 98(6):462-8. PubMed ID: 18683194
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Down-regulation of ATBF1 is a major inactivating mechanism in hepatocellular carcinoma.
    Kim CJ, Song JH, Cho YG, Cao Z, Lee YS, Nam SW, Lee JY, Park WS.
    Histopathology; 2008 Apr 01; 52(5):552-9. PubMed ID: 18312352
    [Abstract] [Full Text] [Related]

  • 12. Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular carcinoma.
    Lv Z, Zhang M, Bi J, Xu F, Hu S, Wen J.
    Am J Clin Pathol; 2006 May 01; 125(5):740-6. PubMed ID: 16707376
    [Abstract] [Full Text] [Related]

  • 13. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, Wang H, Wu M, Zhao J, Guo Y.
    Clin Cancer Res; 2008 Nov 15; 14(22):7405-12. PubMed ID: 19010857
    [Abstract] [Full Text] [Related]

  • 14. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
    Lu CY, Hsieh SY, Lu YJ, Wu CS, Chen LC, Lo SJ, Wu CT, Chou MY, Huang TH, Chang YS.
    Genes Chromosomes Cancer; 2009 Dec 15; 48(12):1057-68. PubMed ID: 19760608
    [Abstract] [Full Text] [Related]

  • 15. DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis.
    Kanai Y, Hui AM, Sun L, Ushijima S, Sakamoto M, Tsuda H, Hirohashi S.
    Hepatology; 1999 Mar 15; 29(3):703-9. PubMed ID: 10051471
    [Abstract] [Full Text] [Related]

  • 16. Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma.
    Hellerbrand C, Mühlbauer M, Wallner S, Schuierer M, Behrmann I, Bataille F, Weiss T, Schölmerich J, Bosserhoff AK.
    Carcinogenesis; 2006 Jan 15; 27(1):64-72. PubMed ID: 16081515
    [Abstract] [Full Text] [Related]

  • 17. NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma.
    Macheiner D, Heller G, Kappel S, Bichler C, Stättner S, Ziegler B, Kandioler D, Wrba F, Schulte-Hermann R, Zöchbauer-Müller S, Grasl-Kraupp B.
    J Hepatol; 2006 Jul 15; 45(1):81-9. PubMed ID: 16516329
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma.
    Schagdarsurengin U, Wilkens L, Steinemann D, Flemming P, Kreipe HH, Pfeifer GP, Schlegelberger B, Dammann R.
    Oncogene; 2003 Mar 27; 22(12):1866-71. PubMed ID: 12660822
    [Abstract] [Full Text] [Related]

  • 20. p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma.
    Li X, Hui AM, Sun L, Hasegawa K, Torzilli G, Minagawa M, Takayama T, Makuuchi M.
    Clin Cancer Res; 2004 Nov 15; 10(22):7484-9. PubMed ID: 15569978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.